Hormonal Contraceptive Market Size, Share | Segmentations, Analysis, Insights, Forecast, Research Report 2025
Increasing disposable income and large unmet contraceptive requirement are the major factor for the growth of this market. According to the new market research report " Global Hormonal Contraceptive Market – Industry Trends - Forecast to 2026", published by Data Bridge Market Research, Global hormonal contraceptive market is set to witness a steady CAGR of 4.54% in the forecast period of 2019- 2026.
Hormonal Contraceptive Market 2019 Industry Report illustrates the present development status of Hormonal Contraceptive along with the growth of Hormonal Contraceptive expected during the forecast period during 2019-2026. Hormonal Contraceptive Market analyses the industry based on different factors like growth trends, consumer volume, and market size, demand and supply status. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability.
Download PDF Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hormonal-contraceptive-market
Market Definition: Hormonal contraceptive are those which are used as a birth control method that usually work on endocrine systems. Some of the common hormonal contraceptives are emergency contraceptive pills, oral contraceptive pills, injectable birth control, transdermal patches and others. They usually act as a estrogen and progesterone during a women cycle with the help of synthetic hormones. Different methods are used and increasing cases of unwanted pregnancy is the factor fueling the growth of this market.
Market Drivers
- Increasing demand to prevent unwanted pregnancy is the factor driving the market
- Rising awareness about contraceptive worldwide will propel market
- Technological advancement and development in contraceptive will also act as a driver for this market
- Increasing initiatives by government and NGO will act as a driver
Market Restraints
- Lack of acceptance by people will restrain the market
- Increasing awareness about the health risk related with the use of contraceptive methods will also hamper market
Browse in-depth TOC on "Hormonal Contraceptive Market"
50 – Tables
250 – No of Figures
150 – Pages
Key Developments in the Market:
- In November 2018, JCR Pharmaceuticals Co., Ltd in collaboration with Amicus Therapeutics, Inc, and GlaxoSmithKline plc launched Agalsidase Beta which is a biosimilar of Fabrazyme in the Japan for the treatment of the lysosomal storage disorder (LSD) Fabry disease (FD). The launch of biosimilar agalsidase beta product significantly improves the treatment option for patients suffering from Fabry disease in the Japan.
- In May 2018, Amicus Therapeutics, Inc, launched Galafold (Migalastat), an oral enzyme replacement therapy for the treatment of Fabry disease in adult patients in the Japan. The launch of Galafold significantly change the treatment landscape for the patients throughout Japan as it is first and only oral precision medicine for Fabry disease in the Japan.
This Hormonal Contraceptive Market report contains all aspects that are directly or indirectly related to the multiple areas of the global market. Our experts have carefully collated the global Hormonal Contraceptive Market data and estimated the change in the forecast period. This information in the report helps customers make accurate decisions about market activity Hormonal Contraceptive Market based on forecasting trends. This report also discusses current or future policy research or regulations that must be initiated by management and market strategies.
Few Of The Major Competitors Currently Working In The Hormonal Contraceptive Market are Sanofi, Takeda Pharmaceutical Company Limited, Amicus Therapeutics, Inc, Moderna, Inc, Greenovation Biotech GmbH, Plant-Based Proteins with Better Therapeutic Profiles, JCR Pharmaceuticals Co., Ltd, ISU ABXIS, Idorsia Pharmaceuticals Ltd, AVROBIO, Inc, Resverlogix Corp., Novartis AG, Pfizer Inc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Enzyvant, CHIESI Farmaceutici SpA, and many others.
Global Hormonal Contraceptive Market Detailed Segmentation:-
By Product
- Oral Contraceptive Pills
- Injectable Birth Control
- Emergency Contraceptive Pills
- Vaginal Rings
- Transdermal Patches
By Hormone
- Androgens
- Estrogens
- Progestogens
- Antiandrogens
- Gonadotropins
- Others
By Age Group
- 15-24 Years
- 25-34 Years
- 35-44 Years
- Above 44 Years
By End- User
- Hospitals
- Household
- Clinics
- Gynecology Centers
- Ambulatory Surgical Centers
Along with the elaborated information about the key contenders, the global Hormonal Contraceptive Market report efficiently provides information by segmenting the market on the basis of the type services and products offerings, form of the product, applications of the final products, technology on which the product is based, and others. The report is also bifurcated the market on the basis of regions to analyze the growth pattern of the market in different geographical areas.
The Hormonal Contraceptive Market report includes the leading advancements and technological up-gradation that engages the user to inhabit with fine business selections, define their future-based priority growth plans, and to implement the necessary actions. The global Hormonal Contraceptive Market report also offers a detailed summary of key players and their manufacturing procedure with statistical data and profound analysis of the products, contribution, and revenue.
This report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Second on basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Hormonal Contraceptive Market, revenue and market share, for key manufacturers.
Buy This Report (Single User Access) @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-hormonal-contraceptive-market
Global Hormonal Contraceptive Market Report includes Detailed TOC points:
1 Introduction
- Objectives Of The Study
- Market Definition
- Overview Of Global Hormonal Contraceptive Market
- Limitations
- Markets Covered
2Market Segmentation
- 1 Markets Covered
- 2 Geographical Scope
- 3 Years Considered For The Study
- 4 Currency And Pricing
- 5 Dbmr Tripod Data Validation Model
- 6 Multivariate Modelling
- 7 Products Lifeline Curve
- 8 Primary Interviews With Key Opinion Leaders
- 9 DBMR Market Position Grid
- 1 Vendor Share Analysis
- 11 Secondary Sources
- 12 Assumptions
3 Market Overview
- 1 Drivers
- .....
3.3 Opportunities
- 3.1 Rising Government Initiatives
- 3.2 Strategic Initiative By Market Players
- 3.3 Rise In Awareness Among The Population
- 3.4 Growing Healthcare Infrastructure
- ....
4 Executive Summaries
5 Premium Insights
6 Regulatory Procedure
7 Global Hormonal Contraceptive Market, By Type
8 Global Hormonal Contraceptive Market, by disease type
9 Global Hormonal Contraceptive Market, By Deployment
10 Global Hormonal Contraceptive Market, By End User
11 Global Hormonal Contraceptive Market, By Distribution Channel
12 Global Hormonal Contraceptive Market, By Geography
13 Global Hormonal Contraceptive Market, Company Landscape
- 1 Company Share Analysis: Global
- 2 Company Share Analysis: North America
- 3 company share analysis: Europe
- 4 company share analysis: Asia-Pacific
14 Company Profile
- 1.1 Company Snapshot
- 1.2 Revenue Analysis
- 1.3 Company Share Analysis
- 1.4 Product Portfolio
- 1.5 Recent Development
Continued…!!!
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475